Evidence map›Paper›PMID 32924754›Full record

Trial reportJournal of the American Heart Association2020

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.

Jennifer A Rymer, Hillary Mulder, Kim G Smolderen, William R Hiatt, Michael S Conte, Jeffrey S Berger, Lars Norgren, Kenneth W Mahaffey, Iris Baumgartner, F Gerry Fowkes and 4 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 4 countries.

Jennifer A RymerDivision of Cardiology Duke University Medical Center Durham NC.
Hillary MulderDuke Clinical Research Institute Durham NC.
Kim G SmolderenVascular Medicine Outcomes Program Yale University New Haven CT.
William R HiattDivision of Cardiology and Colorado Prevention Center University of Colorado School of Medicine Aurora CO.
Michael S ConteDivision of Vascular Surgery University of California San Francisco San Francisco CA.
Jeffrey S BergerDivision of Cardiology NYU Langone Health New York NY.
Lars NorgrenFaculty of Medicine and Health Orebro University Orebro Sweden.
Kenneth W MahaffeyStanford Center for Clinical Research Stanford University School of Medicine Stanford CA.
Iris BaumgartnerSwiss Cardiovascular Center Inselspital Bern University Hospital University of Bern Switzerland.
F Gerry FowkesUsher Institute of Population Health Sciences and Informatics University of Edinburgh United Kingdom.
Brian G KatonaAstraZeneca Gaithersburg MD.
Frank RockholdDuke Clinical Research Institute Durham NC.
W Schuyler JonesDivision of Cardiology Duke University Medical Center Durham NC.
Manesh R PatelDivision of Cardiology Duke University Medical Center Durham NC.
Clinical Research Institute · USAstraZeneca (United States) · USCenter for Clinical Research (United States) · USDuke University · USNYU Langone Health · USÖrebro University · SEUniversity of Bern · CHUniversity of California, San Francisco · USUniversity of Colorado Denver · USUniversity of Edinburgh · GBYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Background There are limited data on health status instruments in patients with peripheral artery disease and cardiovascular and limb events. We evaluated the relationship between health status changes and cardiovascular and limb events. Methods and Results In an analysis of the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) trial, we examined the characteristics of 13 801 patients by tertile of health status instrument scores collected in the trial (EuroQol 5-Dimensions [EQ-5D], EQ visual analog scale [VAS], and peripheral artery questionnaire). We assessed the association between the baseline health status measurements and major adverse cardiovascular events, major adverse limb events, and lower-extremity revascularization procedures during trial follow-up and the association between 12-month health status change scores and subsequent end points during follow-up. There were 13 217 (95%) patients with EQ-5D scores, 13 533 (98%) with VAS scores, and 4431 (32%) with peripheral artery questionnaire scores. Patients in the lowest baseline EQ-5D tertile (0 to <0.69) were more likely to be female with severe claudication compared with the highest tertile (0.79-1.0;

Indexed as

Cardiovascular DiseasesLower ExtremityPeripheral Arterial DiseaseQuality of LifeDouble-Blind MethodFemaleHealth Status IndicatorsHumansMaleMiddle AgedOutcome Assessment, Health CarePlatelet Aggregation InhibitorsSurveys and QuestionnairesSymptom AssessmentTicagrelorVascular Surgical ProceduresPlatelet Aggregation InhibitorsTicagrelorhealth status instrumentsperipheral artery diseasequality of life

Identifiers

PMID32924754
PMCPMC7792388
OpenAlexW3086168271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.